{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:56:52Z","timestamp":1793077012684,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:00:00Z","timestamp":1698537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006304","name":"Aalborg Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.thromres.2023.10.013","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T19:05:30Z","timestamp":1698606330000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia"],"prefix":"10.1016","volume":"232","author":[{"given":"Nour","family":"Al-Hussainy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Hay","family":"Kragholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Lundbye-Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manan","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susette Krohn","family":"Therkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2023.10.013_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0010","first-page":"20","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.013_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2042098617744926","article-title":"Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting","volume":"9","author":"Pandya","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"issue":"12","key":"10.1016\/j.thromres.2023.10.013_bb0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.thromres.2023.10.013_bb0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/ehjqcco\/qcab095","article-title":"Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study","volume":"8","author":"Al-Hussainy","year":"2022","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.013_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.013_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.013_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.thromres.2023.10.013_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S17901","article-title":"Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark","author":"Grann","year":"2011","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.013_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/14017431.2012.673728","article-title":"Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry","volume":"46","author":"Rix","year":"2012","journal-title":"Scand. Cardiovasc. J."},{"issue":"7792","key":"10.1016\/j.thromres.2023.10.013_bb0055","first-page":"320","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2023.10.013_bb0060","series-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","first-page":"1","author":"WHO","year":"2011"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/CLEP.S50449","article-title":"Registration of acute stroke: validity in the Danish stroke registry and the Danish national registry of patients","volume":"6","author":"Wildenschild","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.thromres.2023.10.013_bb0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/CLEP.S400834","article-title":"Positive predictive value of non-traumatic bleeding diagnoses in the Danish National Patient Register","author":"Thaarup","year":"2023","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0962280209105020","article-title":"Pseudo-observations in survival analysis","volume":"19","author":"Perme","year":"2010","journal-title":"Stat. Methods Med. Res. London"},{"key":"10.1016\/j.thromres.2023.10.013_bb0080","author":"Gerds"},{"issue":"10","key":"10.1016\/j.thromres.2023.10.013_bb0090","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Paci fi c Expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.thromres.2023.10.013_bb0095","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","article-title":"Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial","volume":"66","author":"Sherwood","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.thromres.2023.10.013_bb0100","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9921","key":"10.1016\/j.thromres.2023.10.013_bb0105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.thromres.2023.10.013_bb0115","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2016.07.013","article-title":"Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation","volume":"150","author":"Noseworthy","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2023.10.013_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004517","article-title":"Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients","volume":"6","author":"Lamberts","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.013_bb0125","first-page":"639","article-title":"A real-world observational study of hospitalization and health care costs among nonvalvular atrial fibrillation patients prescribed oral anticoagulants in the U.S. Medicare population","volume":"26","author":"Amin","year":"2020","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.013_bb0130","first-page":"1116","article-title":"Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in nonvalvular atrial fibrillation patients in the U.S. Department of Defense population","volume":"24","author":"Gupta","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"9","key":"10.1016\/j.thromres.2023.10.013_bb0135","first-page":"968","article-title":"Major bleeding risk during anticoagulation with warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation","volume":"23","author":"Adeboyeje","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.013_bb0140","first-page":"975","article-title":"Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin: a propensity score matched analysis","volume":"116","author":"Lip","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.013_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ehjcvp\/pvz086","article-title":"Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study","volume":"6","author":"Rutherford","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.013_bb0150","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/j.gastro.2016.12.018","article-title":"Gastrointestinal safety of direct oral anticoagulants: a large population-based study","volume":"152","author":"Abraham","year":"2017","journal-title":"Gastroenterology"},{"issue":"1S Suppl 1","key":"10.1016\/j.thromres.2023.10.013_bb0155","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MEG.0000000000002035","article-title":"Major gastrointestinal bleeding risk with direct oral anticoagulants: does type and dose matter? - a systematic review and network meta-analysis","volume":"33","author":"Radadiya","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.10.013_bb0160","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.thromres.2023.10.013_bb0165","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/03007995.2017.1334638","article-title":"Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients","volume":"33","author":"Deitelzweig","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.thromres.2023.10.013_bb0170","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bcp.13814","article-title":"Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland","volume":"85","author":"Mueller","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.013_bb0175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2147\/CLEP.S219335","article-title":"Differences in gastrointestinal safety profiles among novel oral anticoagulants: evidence from a network meta-analysis","volume":"11","author":"Guo","year":"2019","journal-title":"Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/joim.12683","article-title":"Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study","volume":"283","author":"Staerk","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.thromres.2023.10.013_bb0185","first-page":"679","article-title":"Proton pump inhibitor co-therapy in patients with atrial fibrillation treated with oral anticoagulants and a prior history of upper gastrointestinal tract bleeding","author":"Lee","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.thromres.2023.10.013_bb0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ahj.2020.08.006","article-title":"Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: a nationwide population-based study","volume":"229","author":"Kwon","year":"2020","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.thromres.2023.10.013_bb0195","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/STROKEAHA.119.025536","article-title":"Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation","volume":"50","author":"Lee","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0200","first-page":"1","article-title":"Comparison of once-daily administration of edoxaban and rivaroxaban in Asian patients with atrial fibrillation","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.thromres.2023.10.013_bb0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2023.10.013_bb0215","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1248\/bpb.b21-00230","article-title":"Comparison of the safety and effectiveness of four direct oral anticoagulants in Japanese patients with nonvalvular atrial fibrillation using real-world data","volume":"44","author":"Enomoto","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.013_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40256-016-0189-9","article-title":"Comparing stroke and bleeding with rivaroxaban and dabigatran in atrial fibrillation: analysis of the US Medicare Part D data","volume":"17","author":"Inmaculada Hernandez","year":"2017","journal-title":"Am. J. Cardiovasc. Drugs"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:30Z","timestamp":1758736290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":42,"alternative-id":["S0049384823002906"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.013","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}